GCP
CERE

GSA Capital Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

GSA Capital Partners’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,607
Closed -$577K – 2056
2023
Q4 		$577K Buy
+13,607
New +$577K 0.05% 702
2021
Q4 		– Sell
-25,942
Closed -$765K – 1887
2021
Q3 		$765K Buy
+25,942
New +$765K 0.08% 444